论文部分内容阅读
将26例DF溃疡随机分为两组,观察组13例、对照组13例。观察组用重组人表皮生长因子换药。对照组创面外科清创后,用1%碘伏湿敷。结果:有效率,观察组92.3%,对照组53.8%。观察组疗效明显优于对照组,差异具有显著性(P<0.05)。结论:应用重组人表皮生长因子治疗DF溃疡效果良好。
26 cases of DF ulcer were randomly divided into two groups, the observation group of 13 cases, control group of 13 cases. Observation group with recombinant human epidermal growth factor dressing. Control group, wound surgery debridement, with 1% iodophor wet compress. Results: The effective rate was 92.3% in the observation group and 53.8% in the control group. The observation group was significantly better than the control group, the difference was significant (P <0.05). Conclusion: The effect of recombinant human epidermal growth factor in treating DF ulcer is good.